weekly weight loss semaglutide Blog | Garland Sachse Wylie Murphy Medical clinic Semaglutide for Weight Loss What

Compounded Drugs May Present Further Risks The FDA has issued a warning about using weight loss medications, specifically GLP-1 drugs like semaglutide and tirzepatide, that havent been approved or are compounded differently

Homocysteine and Dementia: An International Consensus Statement

Setting realistic expectations is crucial for any peptide therapy consultation

Patients choose Body Balance Medical because they want real provider oversight not a one-size-fits-all subscription

Patients had a mean age of 48 years (range: 20 to 76 years), 67% were male, 66% were White, 20% were Asian, 8% were American Indian/Alaska Native, and 6% were Black or African American

adults would benefit from treatment with semaglutide